Navigation Links
HemoGenix(R), Inc. Receives Issued Patent for its HALO(R) Technology Platform From the United States Patent and Trademark Office (USPTO).
Date:4/8/2008

This innovative technology has allowed HemoGenix(R) to become "The Leader in Hemotoxicity Testing."

Instrumental in the issuance of the patents by the USPTO were David Rosenbaum and Donna Becker of Rosenbaum & Associates, P.C. of Northbrook, IL. "If it was not for David's interest and belief in HemoGenix and Donna's exuberance in learning and obtaining a thorough understanding of our work and products and her persistence and communication with the USPTO, we would certainly not be in this position today," said Ivan Rich, Ph.D., Founder and CEO of HemoGenix(R). "For a small, but growing company like HemoGenix(R), IP is of fundamental importance to us, not only as validation for what we do, but also for future business, market share and strategic partnerships. This is an important milestone for us. I am extremely grateful to David Rosenbaum and Donna Becker for all the help, assistance and trust they have given us and continue to give us."

About HemoGenix(R), Inc.

HemoGenix(R) Inc., a privately-held contract research and assay development company was started in 2000 in South Carolina and relocated to Colorado Springs, Colorado in 2003. HemoGenix has developed its own portfolio of proprietary and now patented in vitro assay platforms for basic research, stem cell quality control, potency and release assays for stem cell transplantation processing laboratories and toxicity, safety and risk assessment for drug development and environmental testing. HemoGenix(R) develops and validates its in vitro assays first for its contract services and then as assay kits for in house use that are sold directly or through its distributors worldwide.

About Rosenbaum & Associates, P.C.

Rosenbaum & Associates, P.C., located in Northbrook, IL, is a full spectrum intellectual property law firm providing services for the life sciences community. The firm specializes in meeting the needs of start-up and emerging companies and has successfully worked with ind
'/>"/>

SOURCE HemoGenix(R), Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vela Laboratories Receives the GMP Certificate for Its Analytical and Quality Control Laboratories
2. SemBioSys receives milestone payments from AVAC Ltd.
3. Hawaii Biotech Receives Funding From the Pediatric Dengue Vaccine Initiative
4. EntreMed Receives Nasdaq Deficiency Notice
5. Memory Pharmaceuticals Receives Nasdaq Notification
6. Proteolixs Carfilzomib Receives Orphan Drug Designation for Treatment of Multiple Myeloma
7. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
8. Pharmasset Receives $10 Million of Working Capital
9. Memory Pharmaceuticals Receives Audit Opinion Containing Going Concern Qualification
10. Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S.
11. Seneca Valley High School Student Receives Science Award From MedImmune
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , ... July 01, 2015 , ... It is now ... (TBI) using single photon emission computed tomography (SPECT) according to researchers from ... which examined over 20,000 brain scans and is believed to be the largest brain ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus ... the development of groundbreaking drugs to treat neurodegenerative ... today that Robert G. Miller , M.D., Director ... Sutter Health,s California Pacific Medical Center in San Francisco, ... Association for $1.5 million to help fund a ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Apex Therapeutics ... BIO International Convention in Philadelphia, PA. , The presentation took place on ... outlined the plans for the development of APX3330 for the treatment of pancreatic cancer. ...
(Date:6/30/2015)... CALGARY , June 30, 2015 /PRNewswire/ - ... ("Shareholders") of common shares of Resverlogix have approved ... to Eastern Capital Limited of 5,600,000 units at ... Private Placement"), each unit being comprised of one ... for aggregate proceeds of approximately CAD$15 million; and ...
Breaking Biology Technology:Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3
... 2011 To assist U.S. employers in understanding and ... implications of health reform, The Vitality Group , ... paper. The information is publicly available and can be ... (Logo:   http://photos.prnewswire.com/prnh/20110713/CG34519LOGO ) This paper ...
... 2011 Reportlinker.com announces that a new ... catalogue: Industrial Biotechnology China ... In this issue, we ... regulation about biofuel, which include "Instruction for ...
... July 12, 2011 Comprendia, leading developer of ... life sciences, sponsored by molecular biology reagents provider ... online resource that will support epigenetics research. Epigenetics ... for oncology, neurology, metabolism and disease mechanisms.  ,Engaging ...
Cached Biology Technology:The Vitality Group Helps U.S. Businesses Navigate New Legal Environment for Health and Wellness Programs 2Industrial Biotechnology China News 1106 2Industrial Biotechnology China News 1106 3Industrial Biotechnology China News 1106 4Comprendia and New England Biolabs Connect Epigenetics Scientists with New Social Media Application 2Comprendia and New England Biolabs Connect Epigenetics Scientists with New Social Media Application 3
(Date:6/17/2015)... HILDEN, Germany , June 17, 2015 /PRNewswire/ ... Prime Standard: QIA) today launched new Investigator ® STR ... in the United States . The new ... multiple key genomic markers (short tandem repeats or STRs) for ... to evaluate the quality of DNA in each sample, a ...
(Date:6/16/2015)... , June 16, 2015 /CNW Telbec/ - handyem ... centralized around the incorporation of handyem,s HPC-150 portable ... laboratory, the Mo-POD™. This unprecedented model of mobile ... Conference at the Pennsylvania ... June 15 th to 18 th ...
(Date:6/16/2015)... , June 16, 2015 Fingerprint Cards ... communicated that it will amount to at least 340 MSEK ... to the rapid increase in market growth and orders received ... communicated guidance that revenue for 2015 will exceed 1,500 MSEK ... to approximately 2,200 MSEK. Due to receipt of ...
Breaking Biology News(10 mins):QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3
... in Science (via Science Express http://www.sciencexpress.org) on July 28th ... fish in the open ocean ?the largest and least ... of climate change and fishing over the past 50 ... and highlight a surprising global pattern of open ocean ...
... the University of Chicago show how the bacteria that cause ... by slightly altering one of the microbe's tools, the researchers ... , Both papers -- one published online July 28 in ... and Immunity -- focus on aspects of the type-III pathway, ...
... the California Institute of Technology have created the ... This technology may lead to new forms of ... existing methods, as well as revolutionary new instruments ... of physics, applied physics, and bioengineering at Caltech ...
Cached Biology News:Scientists discover global pattern of big fish diversity in open oceans 2Scientists discover global pattern of big fish diversity in open oceans 3Scientists discover global pattern of big fish diversity in open oceans 4Scientists discover global pattern of big fish diversity in open oceans 5Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine 2Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine 3Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine 4Team Invents Device For Weighing Individual Molecules 2Team Invents Device For Weighing Individual Molecules 3
Eppendorf tube holder, for Tube rack 175 x 12 mm, 100. Category: Chromatography Systems & Accessories, Systems....
Pooled normal sreum with 0.1% sodium azide as preservative...
Agarose, pulse field, 250 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
100 adhesive strips....
Biology Products: